References
- Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Eguchi C, Shimora M, Sugimoto T. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Commun 1990; 173: 1093–1101
- Mathews W R, DuCharme D W, Hamlyn J M, Harris D W, Mandel F, Clark M A, Ludens J H. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 1991; 17: 930–935
- Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem 1993; 216: 261–8
- Kramer H J, Krampitz G, Backer A, Krampitz G, Jr., Meyer-Lehnert H. Vanadium-diascorbates are strong candidates for endogenous ouabain-like factors in human urine: effects on Na-K-ATPase enzyme kinetics. Biochem Biophys Res Commun 1995; 213: 289–294
- Bagrov A Y, Dmitrieva R I, Fedorova O V, Kazakov G P, Roukoyatkina N I, Shpen V M. Endogenous marinobufagenin-like immunoreactive substance A possible endogenous Na,K-ATPase inhibitor with vasocostrictor activity. Am J Hypertens 1996; 9: 982–990
- Buckalew V M, Jr., Haddy F J. Circulating natriuretic factors in hypertension. Hypertension: Pathophysiology, diagnosis, and management, J H Laragh, B M Brenner. Raven Press Ltd, New York 1990; 939–954
- Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992; 44: 377–399
- Blaustein M P, Hamlyn J M. Pathogenesis of essential hypertension. A link between dietary salt and high blood pressure. Hypertension 1993; 18: III-184–III-195
- Schöner W. Endogenous digitalis-like factors. Prog Dr Res 1994; 41: 249–291
- Hamlyn J M, Hamilton B P, Manunta P. Endogenous ouabain, sodium balance and blood pressure, a review and a hypothesis. J Hypertens 1996; 14: 151–167
- Tamura M, Harris T M, Phillips D, Blair I A, Wang Y F, Hellerqvist C G, Lam S K, Inagami T. Identification of two cardiac glycosides as Na+-pump inhibitors in rat urine and diet. J Biol Chem 1994; 269: 11972–11979
- Tamura M, Harris T M, Konishi F, Inagami T. Isolation and characterization of an endogenous Na+,K+-ATPase-specific inhibitor from pig urine. Eur J Biochem. 1993; 211: 317–327
- Tamura M, Piston D W, Tani M, Naruse M, Landon E J, Inagami T. Ouabain increases aldosterone release from bovine adrenal glomerulosa cells: role of renin-angiotensin system. Am J Physiol 1996; 270: E27–35
- Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993; 268: 24543–24546
- Kitano S, Morimoto S, Fukuo K, Yasuda S, Kaimoto T, Ogiwara T. Adrenals accumulate exogenous ouabain and may be the origin of plasma ouabain in rats. Ther Res 1993; 14: 201–206
- Tamura M, Lam T-T, Inagami T. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal. Biochemistry 1988; 27: 4244–4253
- Tamura M, Ichiki T, Shiota C, Inagami T. Intracellular cations modulate the expression of the AT2receptor in PC12W cells. FASEB J 1996; 10: A22
- Webb M L, Liu E C-K, Cohen R B, Hedberg A, Bogosian E A, Monshizadegan H, Molloy C, Serafino R, Moreland S, Murphy T J, Dickinson K EJ. Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells. Peptide 1992; 13: 499–508
- Ichiki T, Kambayashi Y, Inagami T. Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. Cir Res 1995; 77: 1070–1076
- Kambayashi Y, Nagata K, Ichiki T, Inagami T. Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells. Eur J Biochem 1996; 239: 558–565